Oncovet Clinical Research
Loos
About Oncovet Clinical Research
Oncovet Clinical Research is a French contract research organization that handles clinical trials on dogs and cats as test subjects for drugs designed for humans. OCR considers ethical standards in researches that involves animals, since they include experimental dogs and cats in new therapies developed for humans. OCR specializes in oncology, inflammation, cardiology, and neurology. It aims to help pharmaceutical organizations invent better medicines for many human illnesses. The company provides clinical trials in comparative medicine that allows for optimization of the drug discovery process and decrease of the attrition rate, as well as filling the gap between pre-clinical and phase I and II human studies. Dominique Tierny and François Serres founded Oncovet Clinical Research in 2011, based in Villeneuve-d'Ascq in France.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Sep 2016)
- Website: oncovet-clinical-research.com
- Phone: +330320568293
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/oncovet-clinical-research-134488 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.